-
公开(公告)号:US08591951B2
公开(公告)日:2013-11-26
申请号:US11191181
申请日:2005-07-27
申请人: Joachim B. Kohn , David Devore , Larisa Sheihet , Robert Dubin
发明人: Joachim B. Kohn , David Devore , Larisa Sheihet , Robert Dubin
CPC分类号: A61K9/5146 , B82Y5/00 , C08G64/045 , C08G64/12 , C08G64/183 , C08G2261/126 , C12N15/88
摘要: Biocompatible non-toxic triblock copolymers having an A-B-A structure wherein each A is a hydrophilic, biocompatible end block and the B middle block is a hydrophobic desaminotyrosyl tyrosine polycarbonate or polyarylate. The copolymers spontaneously self-assemble to form low critical aggregation concentration nanospheres having utility as delivery vehicles for hydrophobic biologically or pharmaceutically active compounds.
摘要翻译: 具有A-B-A结构的生物相容性无毒三嵌段共聚物,其中每个A是亲水的,生物相容的端基和B中间嵌段是疏水性的脱氨基酪氨酸酪氨酸聚碳酸酯或多芳基化合物。 共聚物自发自组装形成低临界聚集浓度的纳米球,其具有用作疏水性生物或药学活性化合物的输送载体。
-
公开(公告)号:US20090317472A1
公开(公告)日:2009-12-24
申请号:US12525529
申请日:2008-01-31
申请人: Joachim B. Kohn , Bozena Michniak , David Devore , Larisa Sheihet , Prafulla Chandra , Priya Batheja
发明人: Joachim B. Kohn , Bozena Michniak , David Devore , Larisa Sheihet , Prafulla Chandra , Priya Batheja
CPC分类号: A61K9/0014 , A61K8/90 , A61K9/5153 , A61K2800/412 , A61K2800/413 , A61Q5/02 , A61Q5/12 , A61Q15/00 , A61Q17/04 , A61Q19/00 , A61Q19/02 , A61Q19/04 , B82Y5/00 , Y02A50/401
摘要: Topical compositions are provided in which active compounds for topical delivery through the stratum corneum are complexed with nanospheres of a triblock copolymer having an A-B-A structure wherein each A end block is a water-soluble, hydrophilic and non-toxic polymer or oligomer; and the hydrophobic middle B block is a hydrophobic polymer or oligomer with the same or different repeating units having the structure according to formula:(I) wherein X is —C —R—C— or —C—; Z is between 2 and about 100, inclusive; R1 is CH═CH or (CH2), wherein n is from 0 to 18, inclusive; R2 is selected from hydrogen and straight and branched alkyl, alkoxy, alkylaryl and alkoxyaryl groups containing up to 18 carbon atoms; and R is selected from a bond or straight and branched alkyl, alkoxy, alkylaryl and alkoxyaryl groups containing up to 18 carbon atoms.
摘要翻译: 提供了局部组合物,其中通过角质层局部递送的活性化合物与具有A-B-A结构的三嵌段共聚物的纳米球络合,其中每个A端嵌段是水溶性的,亲水的和无毒的聚合物或低聚物; 并且疏水性中间B嵌段是具有相同或不同重复单元的疏水性聚合物或低聚物,其具有根据下式的结构:(I)其中X是-C-C-C或-C-; Z在2至约100之间(含); R1为CH-CH或(CH2),其中n为0至18,包括端值; R2选自氢和含有至多18个碳原子的直链和支链烷基,烷氧基,烷基芳基和烷氧基芳基; 并且R选自含有至多18个碳原子的键或直链和支链烷基,烷氧基,烷基芳基和烷氧基芳基。
-
公开(公告)号:US20060013882A1
公开(公告)日:2006-01-19
申请号:US11191181
申请日:2005-07-27
申请人: Joachim Kohn , David Devore , Larisa Sheihet , Robert Dubin
发明人: Joachim Kohn , David Devore , Larisa Sheihet , Robert Dubin
CPC分类号: A61K9/5146 , B82Y5/00 , C08G64/045 , C08G64/12 , C08G64/183 , C08G2261/126 , C12N15/88
摘要: Biocompatible non-toxic triblock copolymers having an A-B-A structure wherein each A is a hydrophilic, biocompatible end block and the B middle block is a hydrophobic desaminotyrosyl tyrosine polycarbonate or polyarylate. The copolymers spontaneously self-assemble to form low critical aggregation concentration nanospheres having utility as delivery vehicles for hydrophobic biologically or pharmaceutically active compounds.
-
公开(公告)号:US08414871B2
公开(公告)日:2013-04-09
申请号:US12525529
申请日:2008-01-31
申请人: Joachim Kohn , Bozena Michniak , David Devore , Larisa Sheihet , Prafulla Chandra , Priya Batheja
发明人: Joachim Kohn , Bozena Michniak , David Devore , Larisa Sheihet , Prafulla Chandra , Priya Batheja
IPC分类号: A61K8/72
CPC分类号: A61K9/0014 , A61K8/90 , A61K9/5153 , A61K2800/412 , A61K2800/413 , A61Q5/02 , A61Q5/12 , A61Q15/00 , A61Q17/04 , A61Q19/00 , A61Q19/02 , A61Q19/04 , B82Y5/00 , Y02A50/401
摘要: Topical compositions are provided in which active compounds for topical delivery through the stratum corneum are complexed with nanospheres of a triblock copolymer having an A-B-A structure wherein each A end block is a water-soluble, hydrophilic and non-toxic polymer or oligomer; and the hydrophobic middle B block is a hydrophobic polymer or oligomer with the same or different repeating units having the structure according to formula:(I) wherein X is —C—R—C— or —C—; Z is between 2 and about 100, inclusive; R1 is CH═CH or (CH2), wherein n is from 0 to 18, inclusive; R2 is selected from hydrogen and straight and branched alkyl, alkoxy, alkylaryl and alkoxyaryl groups containing up to 18 carbon atoms; and R is selected from a bond or straight and branched alkyl, alkoxy, alkylaryl and alkoxyaryl groups containing up to 18 carbon atoms.
摘要翻译: 提供了局部组合物,其中通过角质层局部递送的活性化合物与具有A-B-A结构的三嵌段共聚物的纳米球络合,其中每个A端嵌段是水溶性的,亲水的和无毒的聚合物或低聚物; 疏水性中间B嵌段是具有相同或不同的具有下式结构的重复单元的疏水聚合物或低聚物:其中X是-C(= O)-R-C(= O) - 或-C (= O) - ; Z在2至约100之间(含); R1为CH = CH或(CH2)n,其中n为0至18,包括端值; R2选自氢和含有至多18个碳原子的直链和支链烷基,烷氧基,烷基芳基和烷氧基芳基; 并且R选自含有至多18个碳原子的键或直链和支链烷基,烷氧基,烷基芳基和烷氧基芳基。
-
公开(公告)号:US07550282B2
公开(公告)日:2009-06-23
申请号:US10534469
申请日:2003-11-18
申请人: Shlomo Margel , Larisa Sheihet , Tamar Tennenbaum
发明人: Shlomo Margel , Larisa Sheihet , Tamar Tennenbaum
CPC分类号: A61L24/106 , A61K31/00 , A61K33/06 , A61K38/45 , A61K38/4833 , A61K45/06 , A61K47/643 , A61K47/6923 , A61K47/6929 , A61L2400/12 , B82Y5/00 , C07B2200/11 , C40B40/04 , A61K2300/00
摘要: Thrombin-conjugated nanoparticles, wherein said nanoparticles comprise one or more organic and/or inorganic compounds and process for preparing the same are provided. The thrombin-conjugated nanoparticles are suitable for use in the preparation of fibrin-based biological sealant.
摘要翻译: 凝血酶缀合的纳米颗粒,其中所述纳米颗粒包含一种或多种有机和/或无机化合物,并提供其制备方法。 凝血酶缀合的纳米颗粒适用于制备基于纤维蛋白的生物密封剂。
-
公开(公告)号:US20060104970A1
公开(公告)日:2006-05-18
申请号:US10534469
申请日:2003-11-18
申请人: Shlomo Margel , Larisa Sheihet , Tamar Tennenbaum
发明人: Shlomo Margel , Larisa Sheihet , Tamar Tennenbaum
CPC分类号: A61L24/106 , A61K31/00 , A61K33/06 , A61K38/45 , A61K38/4833 , A61K45/06 , A61K47/643 , A61K47/6923 , A61K47/6929 , A61L2400/12 , B82Y5/00 , C07B2200/11 , C40B40/04 , A61K2300/00
摘要: Thrombin-conjugated nanoparticles, wherein said nanoparticles comprise one or more organic and/or inorganic compounds and process for preparing the same are provided. The thrombin-conjugated nanoparticles are suitable for use in the preparation of fibrin-based biological sealant.
-
-
-
-
-